Largest health care companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
UnitedHealth Group leads the 170 health care companies ranked by cash on hand, at NOK 237.5B, ahead of Johnson & Johnson (NOK 192.1B) and Centene (NOK 174.4B). Figures as of 20 Nov 2026, 13:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupNOK 237.5B
- Median
- NOK 5.7B
- Combined market value
- NOK 86.96T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Merit Medical SystemsMMSI · Health Care | NOK 4.4B | NOK 49.3B | NOK 822.82 | 1.77% down | 3% down | ||
| 102 | STERISSTE · Health Care | NOK 4.3B | NOK 241.2B | NOK 2,483.39 | 1.85% down | 3% down | ||
| 103 | Quest DiagnosticsDGX · Health Care | NOK 4.1B | NOK 277.9B | NOK 2,525.60 | 0.23% down | 35% up | ||
| 104 | AlkermesALKS · Health Care | NOK 3.8B | NOK 75.6B | NOK 450.16 | 1.43% down | 61% up | ||
| 105 | Revolution MedicinesRVMD · Health Care | NOK 3.7B | NOK 336.1B | NOK 1,554.12 | 0.24% down | 125% up | ||
| 106 | Bausch + LombBLCO · Health Care | NOK 3.7B | NOK 72.1B | NOK 201.69 | 1.24% down | 37% up | ||
| 107 | TeleflexTFX · Health Care | NOK 3.7B | NOK 63.2B | NOK 1,592.82 | 1.48% down | 48% up | ||
| 108 | Guardant HealthGH · Health Care | NOK 3.7B | NOK 192B | NOK 1,419.20 | 0.31% up | 38% up | ||
| 109 | Ionis PharmaceuticalsIONS · Health Care | NOK 3.6B | NOK 44.2B | NOK 265.34 | 0.62% down | 64% down | ||
| 110 | AvantorAVTR · Health Care | NOK 3.6B | NOK 99.9B | NOK 147.39 | 1.63% down | 31% up | ||
| 111 | Lantheus HoldingsLNTH · Health Care | NOK 3.5B | NOK 65.1B | NOK 995.27 | 0.10% up | 83% up | ||
| 112 | Praxis Precision MedicinesPRAX · Health Care | NOK 3.5B | NOK 84.7B | NOK 3,030.64 | 1.87% up | 83% up | ||
| 113 | Kymera TherapeuticsKYMR · Health Care | NOK 3.5B | NOK 99.4B | NOK 1,163.81 | 1.44% down | 81% up | ||
| 114 | Belite BioBLTE · Health Care | NOK 3.4B | NOK 59.8B | NOK 1,472.14 | 3.33% down | 25% up | ||
| 115 | CRISPR TherapeuticsCRSP · Health Care | NOK 3.4B | NOK 36.8B | NOK 379.49 | 3.14% down | 22% down | ||
| 116 | Scholar Rock HoldingSRRK · Health Care | NOK 3.2B | NOK 59.9B | NOK 491.00 | 4.94% up | 25% up | ||
| 117 | Axsome TherapeuticsAXSM · Health Care | NOK 3.1B | NOK 69.6B | NOK 1,322.60 | 1.25% up | 9% down | ||
| 118 | HealthEquityHQY · Health Care | NOK 3.1B | NOK 78.5B | NOK 949.26 | 0.07% up | 4% down | ||
| 119 | Cogent BiosciencesCOGT · Health Care | NOK 3B | NOK 47B | NOK 270.41 | 0.25% down | 25% down | ||
| 120 | BrukerBRKR · Health Care | NOK 2.9B | NOK 92.5B | NOK 605.35 | 1.83% down | 31% up | ||
| 121 | MiniMed GroupMMED · Health Care | NOK 2.9B | NOK 44.6B | NOK 158.50 | 4.30% down | 12% down | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | NOK 2.9B | NOK 60.8B | NOK 931.03 | 3.27% up | 35% up | ||
| 123 | Amneal PharmaceuticalsAMRX · Health Care | NOK 2.7B | NOK 72.6B | NOK 208.51 | 2.24% down | 79% up | ||
| 124 | Bio-TechneTECH · Health Care | NOK 2.6B | NOK 111.3B | NOK 708.68 | 0.07% down | 18% up | ||
| 125 | Definium TherapeuticsDFTX · Health Care | NOK 2.5B | NOK 39.3B | NOK 287.37 | 1.24% up | 176% up | ||
| 126 | GRAILGRAL · Health Care | NOK 2.4B | NOK 46B | NOK 1,021.98 | 2.68% up | 12% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | NOK 2.4B | NOK 49.4B | NOK 130.04 | 3.12% down | 107% up | ||
| 128 | HaemoneticsHAE · Health Care | NOK 2.4B | NOK 53.4B | NOK 1,173.36 | 2.03% down | 53% up | ||
| 129 | Option Care HealthOPCH · Health Care | NOK 2.3B | NOK 46.2B | NOK 308.13 | 0.32% down | 7% up | ||
| 130 | Hims & Hers HealthHIMS · Health Care | NOK 2.2B | NOK 36.6B | NOK 156.16 | 6.04% down | 54% down | ||
| 131 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 2.2B | NOK 60.2B | NOK 425.50 | 1.25% up | 8% up | ||
| 132 | Summit TherapeuticsSMMT · Health Care | NOK 2.2B | NOK 82.4B | NOK 103.04 | 0.67% up | 35% down | ||
| 133 | Charles River Laboratories InternationalCRL · Health Care | NOK 2.1B | NOK 153.2B | NOK 3,196.65 | 1.60% down | 96% up | ||
| 134 | Kodiak SciencesKOD · Health Care | NOK 2B | NOK 62.4B | NOK 954.32 | 0.09% up | 371% up | ||
| 135 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 1.9B | NOK 89.8B | NOK 3,867.40 | 0.34% down | 28% down | ||
| 136 | PACS GroupPACS · Health Care | NOK 1.9B | NOK 66.6B | NOK 419.45 | 7.06% down | 56% up | ||
| 137 | PenumbraPEN · Health Care | NOK 1.8B | NOK 123B | NOK 3,119.44 | 0.18% down | 11% up | ||
| 138 | Twist BioscienceTWST · Health Care | NOK 1.8B | NOK 74.2B | NOK 1,088.07 | 4.07% down | 291% up | ||
| 139 | IDEXX LaboratoriesIDXX · Health Care | NOK 1.8B | NOK 529.7B | NOK 6,722.67 | 1.26% down | 5% down | ||
| 140 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.7B | NOK 55.9B | NOK 2,797.08 | 3.94% down | 44% up | ||
| 141 | VaxcytePCVX · Health Care | NOK 1.7B | NOK 90.1B | NOK 568.89 | 0.27% down | 22% up | ||
| 142 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 1.6B | NOK 71.6B | NOK 911.77 | 1.59% down | 125% up | ||
| 143 | MSA SafetyMSA · Health Care | NOK 1.6B | NOK 66.2B | NOK 1,717.98 | 0.68% down | 13% up | ||
| 144 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 1.6B | NOK 120.5B | NOK 144.56 | 1.00% down | 7% up | ||
| 145 | Henry ScheinHSIC · Health Care | NOK 1.5B | NOK 91.4B | NOK 826.63 | 1.04% down | 16% up | ||
| 146 | Universal Health ServicesUHS · Health Care | NOK 1.3B | NOK 98.3B | NOK 1,705.70 | 5.96% down | 25% down | ||
| 147 | Halozyme TherapeuticsHALO · Health Care | NOK 1.3B | NOK 103.4B | NOK 906.95 | 2.88% down | 32% up | ||
| 148 | Protagonist TherapeuticsPTGX · Health Care | NOK 1.3B | NOK 78.9B | NOK 1,208.94 | 2.47% down | 45% up | ||
| 149 | CytokineticsCYTK · Health Care | NOK 1.2B | NOK 69.9B | NOK 501.63 | 0.27% up | 21% down | ||
| 150 | Corcept TherapeuticsCORT · Health Care | NOK 1.2B | NOK 69.3B | NOK 633.42 | 4.15% down | 16% down | ||
| 151 | Cooper CompaniesCOO · Health Care | NOK 1.1B | NOK 111.8B | NOK 588.09 | 0.69% down | 20% down | ||
| 152 | Travere TherapeuticsTVTX · Health Care | NOK 906.9M | NOK 45.2B | NOK 470.83 | 3.86% down | 39% up | ||
| 153 | GlaukosGKOS · Health Care | NOK 885.2M | NOK 137.4B | NOK 2,320.99 | 2.15% up | 139% up | ||
| 154 | BrightSpring Health ServicesBTSG · Health Care | NOK 861.4M | NOK 124.2B | NOK 624.06 | 6.32% down | 85% up | ||
| 155 | ImmunityBioIBRX · Health Care | NOK 861.1M | NOK 68.1B | NOK 64.04 | 1.94% down | 216% up | ||
| 156 | Spyre TherapeuticsSYRE · Health Care | NOK 835.6M | NOK 90.4B | NOK 951.69 | 3.77% down | 302% up | ||
| 157 | Concentra Group Holdings ParentCON · Health Care | NOK 778.9M | NOK 50.8B | NOK 404.05 | 1.12% down | 105% up | ||
| 158 | TG TherapeuticsTGTX · Health Care | NOK 771.5M | NOK 95.6B | NOK 632.45 | 1.88% down | 103% up | ||
| 159 | ChemedCHE · Health Care | NOK 726.4M | NOK 69.7B | NOK 5,374.34 | 0.84% up | 25% up | ||
| 160 | ErascaERAS · Health Care | NOK 719.4M | NOK 48.6B | NOK 138.62 | 3.34% up | 387% up | ||
| 161 | Encompass HealthEHC · Health Care | NOK 703.8M | NOK 126.5B | NOK 1,289.46 | 1.96% down | 16% up | ||
| 162 | Adaptive BiotechnologiesADPT · Health Care | NOK 687.2M | NOK 44.3B | NOK 273.43 | 1.44% down | 51% up | ||
| 163 | Mettler-Toledo InternationalMTD · Health Care | NOK 652M | NOK 330.7B | NOK 16,626.69 | 1.82% down | 17% up | ||
| 164 | Edgewise TherapeuticsEWTX · Health Care | NOK 596.1M | NOK 43.9B | NOK 401.32 | 0.48% down | 82% up | ||
| 165 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 529.3M | NOK 78.9B | NOK 1,138.56 | 1.88% down | 15% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | NOK 498M | NOK 46.6B | NOK 826.92 | 1.01% up | 105% up | ||
| 167 | Oruka TherapeuticsORKA · Health Care | NOK 457.5M | NOK 64.5B | NOK 951.11 | 1.91% up | 233% up | ||
| 168 | HeartflowHTFL · Health Care | NOK 436.5M | NOK 38.2B | NOK 435.05 | 2.75% down | 45% up | ||
| 169 | CG OncologyCGON · Health Care | NOK 316.7M | NOK 71.3B | NOK 798.36 | 2.38% up | 93% up | ||
| 170 | VeradermicsMANE · Health Care | NOK 212.2M | NOK 51.2B | NOK 1,212.55 | 0.38% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7479 NOK).
Questions and answers
Which health care companies rank first by cash on hand?
UnitedHealth Group (NOK 237.5B), Johnson & Johnson (NOK 192.1B) and Centene (NOK 174.4B) are the top three of the 170 health care companies ranked by cash on hand as of 20 Nov 2026, 13:40 UTC.
How many health care companies are in this ranking?
170 are ranked by cash on hand.
What are these health care companies worth together?
The 170 health care companies ranked by cash on hand have a combined market value of NOK 86.96T as of 20 Nov 2026, 13:40 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by cash on hand”, data as of 20 November 2026. https://funkfolio.com/companies/sector/health-care?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.